Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-26 @ 3:25 AM
Study NCT ID:
NCT04289220
Status:
UNKNOWN
Last Update Posted:
2021-05-13
First Post:
2020-02-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia
Sponsor:
Yan'an Affiliated Hospital of Kunming Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09-15
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-26
First Submit QC Date:
None
Study First Post Date:
2020-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-12
Last Update Post Date:
2021-05-13
Last Update Post Date Type:
ACTUAL